Published in J Virol on March 01, 1993
Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J (1993) 1.39
The kinetics of simian virus 40-induced progression of quiescent cells into S phase depend on four independent functions of large T antigen. J Virol (1994) 1.22
Tiny T antigen: an autonomous polyomavirus T antigen amino-terminal domain. J Virol (1997) 1.10
Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J Virol (1995) 1.00
MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J Virol (1997) 0.92
Dissociation of retinoblastoma gene protein hyperphosphorylation and commitment to enter S phase. J Virol (1994) 0.88
Wild-type p53 enhances efficiency of simian virus 40 large-T-antigen-induced cellular transformation. J Virol (2009) 0.83
Simian virus 40 small t antigen activates the carboxyl-terminal transforming p53-binding domain of large T antigen. J Virol (1996) 0.79
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol (1991) 15.04
Construction and analysis of viable deletion mutants of simian virus 40. J Virol (1976) 9.11
A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol (1985) 7.66
Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proc Natl Acad Sci U S A (1979) 6.94
Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell (1990) 6.12
Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells. Cell (1978) 5.23
New region of the simian virus 40 genome required for efficient viral transformation. Proc Natl Acad Sci U S A (1978) 4.24
Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc Natl Acad Sci U S A (1990) 3.76
The roles of the simian virus 40 tumor antigens in transformation of Chinese hamster lung cells. Cell (1979) 3.57
Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions. J Virol (1982) 3.18
Large and small tumor antigens from simian virus 40 have identical amino termini mapping at 0.65 map units. Proc Natl Acad Sci U S A (1978) 3.00
Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol Cell Biol (1986) 2.81
Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol Cell Biol (1991) 2.80
The replication functions of SV40 T antigen are regulated by phosphorylation. Cell (1990) 2.51
Cellular proteins associated with simian virus 40 early gene products in newly infected cells. J Virol (1979) 2.44
SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell (1987) 2.13
Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen. J Virol (1986) 2.11
Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J Virol (1992) 2.02
Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol (1991) 1.99
trans-activation of RNA polymerase II and III promoters by SV40 small t antigen. Cell (1988) 1.98
Transformation mediated by the SV40 T antigens: separation of the overlapping SV40 early genes with a retroviral vector. Cell (1984) 1.98
Viable deletion mutants in the simian virus 40 early region. Proc Natl Acad Sci U S A (1978) 1.89
Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. EMBO J (1989) 1.83
The simian virus 40 large T antigen. A lot packed into a little. Mol Biol Med (1987) 1.77
Role of small t antigen in the acute transforming activity of SV40. Cell (1982) 1.76
A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth. J Virol (1986) 1.68
Cellular and cell-free synthesis of simian virus 40 T-antigens in permissive and transformed cells. J Virol (1978) 1.66
Complete interaction of cellular 56,000- and 32,000-Mr proteins with simian virus 40 small-t antigen in productively infected cells. J Virol (1987) 1.63
Growth state of the cell early after infection with simian virus 40 determines whether the maintenance of transformation will be A-gene dependent or independent. J Virol (1979) 1.51
Mapping the transcriptional transactivation function of simian virus 40 large T antigen. J Virol (1991) 1.47
I. In vitrol transformation of rat embryo cells: correlations with the known tumorigenic activities of chemicals in rodents. In Vitro (1975) 1.42
Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice. Mol Cell Biol (1988) 1.40
Transformation by purified early genes of simian virus 40. Virology (1984) 1.31
Simian virus 40 small tumor antigen and an amino-terminal domain of large tumor antigen share a common transforming function. Proc Natl Acad Sci U S A (1990) 1.27
Biochemical characterization of phosphorylation site mutants of simian virus 40 large T antigen: evidence for interaction between amino- and carboxy-terminal domains. J Virol (1991) 1.23
Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses. J Virol (1984) 1.21
Phosphorylation of simian virus 40 large T antigen: cytoplasmic and nuclear phophorylation sites differ in their metabolic stability. Virology (1986) 1.20
Protein phosphatase 2A dephosphorylates simian virus 40 large T antigen specifically at residues involved in regulation of DNA-binding activity. J Virol (1991) 1.19
The t-unique coding domain is important to the transformation maintenance function of the simian virus 40 small t antigen. Mol Cell Biol (1986) 1.16
Interaction of simian virus 40 small-T antigen produced in bacteria with 56K and 32K proteins of animal cells. J Virol (1985) 1.13
Mutational analysis of simian virus 40 small-t antigen. J Virol (1990) 1.13
Differential requirement for SV40 early genes in immortalization and transformation of primary rat and human embryonic cells. Virology (1985) 1.07
The kinase activity of SV40 large T antigen is mediated by a cellular kinase. EMBO J (1986) 1.01
Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cells. Oncogene (1991) 0.97
Involvement of simian virus 40 (SV40) small t antigen in trans activation of SV40 early and late promoters. J Virol (1992) 0.96
Simian virus 40 small t antigen trans activates the adenovirus E2A promoter by using mechanisms distinct from those used by adenovirus E1A. J Virol (1992) 0.95
Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene (1992) 0.89
Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells. J Virol (1992) 0.86
Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants. J Virol (1991) 0.83
Enhanced protein phosphorylation in SV40-transformed and -infected cells. Virology (1987) 0.83
The cellular chromatin is an important target for SV40 large T antigen in maintaining the transformed phenotype. Virology (1990) 0.81
On the functional roles of simian virus 40 large and small T-antigen in the induction of a mitotic host response. Nucleic Acids Res (1986) 0.80
Negative feedback regulation of wild-type p53 biosynthesis. EMBO J (1995) 2.52
Different structural systems of the nucleus are targets for SV40 large T antigen. Cell (1983) 2.18
Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen. J Virol (1986) 2.11
Preparation of nuclear matrices from cultured cells: subfractionation of nuclei in situ. J Cell Biol (1984) 2.07
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev (2001) 2.05
DNA binding properties of murine p53. Oncogene (1988) 1.85
Intermolecular disulfide bonds: an important structural feature of the polyoma virus capsid. Cold Spring Harb Symp Quant Biol (1975) 1.72
Acylated simian virus 40 large T-antigen: a new subclass associated with a detergent-resistant lamina of the plasma membrane. EMBO J (1983) 1.55
Simian virus to (SV40) tumor-specific proteins in nucleus and plasma membrane of HeLa cells infected by adenovirus 2-SV40 hybrid virus Ad2+ND2. Proc Natl Acad Sci U S A (1976) 1.49
Monoclonal antibodies against simian virus 40 tumor antigens: analysis of antigenic binding sites, using adenovirus type 2-simian virus 40 hybrid viruses. J Virol (1981) 1.44
Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J (1993) 1.39
Simian virus 40 T-antigen-related cell surface antigen: serological demonstration on simian virus 40-transformed monolayer cells in situ. J Virol (1980) 1.36
p53 Protein exhibits 3'-to-5' exonuclease activity. Cell (1996) 1.36
Intermediate filament systems are collapsed onto the nuclear surface after isolation of nuclei from tissue culture cells. Exp Cell Res (1982) 1.36
IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene (2000) 1.36
Domains of simian virus 40 large T-antigen exposed on the cell surface. Virology (1982) 1.29
Cell surface location of simian virus 40-specific proteins on HeLa cells infected with adenovirus type 2-simian virus 40 hybrid viruses Ad2+ND1 and Ad2+ND2. J Virol (1979) 1.28
Simian virus 40 tumor-specific proteins: subcellular distribution and metabolic stability in HeLa cells infected with nondefective adenovirus type 2-simian virus 40 hybrid viruses. J Virol (1977) 1.22
Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells. Mol Cell Biol (1986) 1.20
A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene (2000) 1.18
SV40 T-antigen-related molecules on the surfaces of HeLa cells infected with adenovirus-2-SV40 hybrids and on SV40-transformed cells. Cold Spring Harb Symp Quant Biol (1980) 1.14
Nuclear subcompartmentalization of simian virus 40 large T antigen: evidence for in vivo regulation of biochemical activities. J Virol (1989) 1.12
Specific interaction of simian virus 40 large T antigen with cellular chromatin and nuclear matrix during the course of infection. J Virol (1987) 1.11
Acylation: a new post-translational modification specific for plasma membrane-associated simian virus 40 large T-antigen. FEBS Lett (1983) 1.10
Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene (2006) 1.10
Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J Immunol (1998) 1.09
Interaction of casein kinase 1 delta (CK1delta) with post-Golgi structures, microtubules and the spindle apparatus. Eur J Cell Biol (2000) 1.07
Dissociation of the recombination control and the sequence-specific transactivation function of P53. Oncogene (1999) 1.07
Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. I. Subcellular localization during the course of infection. J Virol (1981) 1.07
Simian virus 40 specific proteins on surface of HeLa cells infected with adenovirus 2--SV40 hybrid virus Ad2+ND2. Nature (1979) 1.05
Differentiation between intracellular and cell surface glycosyl transferases: galactosyl transferase activity in intact cells and in cell homogenate. Proc Natl Acad Sci U S A (1974) 1.05
The dual role model for p53 in maintaining genomic integrity. Cell Mol Life Sci (1999) 1.04
Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination. Mol Cell Biol (1998) 1.04
Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene (1999) 1.03
Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene (2009) 1.03
Structural topography of simian virus 40 DNA replication. J Virol (1991) 1.02
SV40-transformed cells express SV40 T antigen-related antigens on the cell surface. Virology (1981) 1.02
DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53. Oncogene (1997) 1.02
Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53. Oncogene (1993) 1.01
The kinase activity of SV40 large T antigen is mediated by a cellular kinase. EMBO J (1986) 1.01
Emergence of virus escape mutants after immunization with epitope vaccine. J Virol (1995) 1.01
The versatile interactions of p53 with DNA: when flexibility serves specificity. Cell Death Differ (2006) 1.00
Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J Virol (1995) 1.00
Membrane interactions of simian virus 40 large T-antigen: influence of protein sequences and fatty acid acylation. Mol Cell Biol (1984) 1.00
Analysis of biological and biochemical parameters for chromatin and nuclear matrix association of SV40 large T antigen in transformed cells. Oncogene (1987) 1.00
Gadd45 beta is a pro-survival factor associated with stress-resistant tumors. Oncogene (2007) 0.99
Simian virus 40 T- and U-antigens: immunological characterization and localization in different nuclear subfractions of simian virus 40-transformed cells. J Virol (1979) 0.99
Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene (1996) 0.98
A new sensitive target-bound DNA binding assay for SV40 large T antigen. Virology (1986) 0.97
CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. Oncogene (2011) 0.96
Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53. Oncogene (2000) 0.96
Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J Virol (1994) 0.95
Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53. Oncogene (1999) 0.95
Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene (1995) 0.94
Late nonstructural 100,000- and 33,000-dalton proteins of adenovirus type 2. II. Immunological and protein chemical analysis. J Virol (1981) 0.94
Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol Cell Biol (2001) 0.94
CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J Immunol (1994) 0.93
MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J Virol (1997) 0.92
Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency. Oncogene (1994) 0.92
Mapping of a DNA-binding domain of simian virus 40 T-antigen using non-defective adenovirus 2--simian virus 40 hybrid viruses. FEBS Lett (1982) 0.92
Regulation of cellular senescence by Rb2/p130. Oncogene (2006) 0.92
Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing. Proc Natl Acad Sci U S A (1998) 0.91
Interactions of mutant p53 with DNA: guilt by association. Oncogene (2007) 0.91
Specific binding of MAR/SAR DNA-elements by mutant p53. Oncogene (1996) 0.91
Overexpression of p53 protein during pancreatitis. Br J Cancer (1997) 0.91
Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene (1992) 0.89
SV40 T-antigen-related surface antigen: correlated expression with nuclear T-antigen in cells transformed by an SV40 A-gene mutant. Virology (1980) 0.89
Simian virus 40 (SV40)-specific proteins associated with the nuclear matrix isolated from adenovirus type 2-SV40 hybrid virus-infected HeLa cells carry SV40 U-antigen determinants. J Virol (1978) 0.89
Specific complex of the late nonstructural 100,000-dalton protein with newly synthesized hexon in adenovirus type 2-infected cells. Virology (1983) 0.89
Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ (2006) 0.89
Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression. Oncogene (1990) 0.89
Acylated simian virus 40-specific proteins in the plasma membrane of HeLa cells infected with adenovirus 2-simian virus 40 hybrid virus Ad2+ND2. Virology (1983) 0.89
Progressive reorganization of the host cell cytoskeleton during adenovirus infection. J Virol (1986) 0.88
Detection of simian virus 40 T-antigen-related antigens by a 125I-protein A-binding assay and by immunofluorescence microscopy on the surface of SV40-transformed monolayer cells. J Gen Virol (1981) 0.88
Nuclear matrix preparations from liver tissue and from cultured vertebrate cells: differences in major polypeptides. Eur J Cell Biol (1983) 0.88
p53 and mdm2 are expressed independently during cellular proliferation. Oncogene (1994) 0.88
Evidence for transmembrane orientation of acylated simian virus 40 large T antigen. J Virol (1985) 0.88
Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha. Oncogene (1999) 0.87
Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (vimentin) scaffold. Oncogene (1998) 0.87
Mutant p53 protein, master regulator of human malignancies: a report on the Fifth Mutant p53 Workshop. Cell Death Differ (2011) 0.87
Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells. J Virol (1992) 0.86
Identification of genomic DNA sequences bound by mutant p53 protein (Gly245-->Ser) in vivo. Oncogene (2000) 0.85
In vivo acylation of Dictyostelium actin with palmitic acid. EMBO J (1985) 0.85
Analysis of mechanisms controlling the interactions of SV40 large T antigen with the SV40 ORI region. Virology (1988) 0.85
Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes. Eur J Immunol (1993) 0.85
Phosphorylation of p53 in primary, immortalised and transformed Balb/c mouse cells. Oncogene (1990) 0.85
Comparative assessment of the functional p53 status in glioma cells. Anticancer Res (2005) 0.84
TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression. Int J Oncol (1999) 0.84
The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene. Oncogene (1998) 0.84
Specific and complex interactions of murine p53 with DNA. Oncogene (1992) 0.83
Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants. J Virol (1991) 0.83
Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice. Eur J Immunol (1992) 0.83
Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. Oncogene (1995) 0.82
Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53. Nucleic Acids Res (1995) 0.82
Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes. J Immunol (1996) 0.82
High affinity MAR-DNA binding is a common property of murine and human mutant p53. J Cell Biochem (1998) 0.82
Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding. Mol Cell Biol (1999) 0.81
Wild-type p53 is not a negative regulator of simian virus 40 DNA replication in infected monkey cells. J Virol (1993) 0.81